Graves' disease | Hashimoto's thyroiditis | Controls | |
---|---|---|---|
ERα polymorphism | n=130, (260 alleles), (%) | n=93, (186 alleles), (%) | n=190, (380 alleles), (%) |
allele *1 | 20 (7.7%) | 13 (7.0%) | 24 (6.3%) |
allele *2 | 40 (15.3%) | 34 (18.3%) | 88 (23.2%) |
allele *3 | 49 (18.7%) | 25 (13.4%) | 58 (15.3%) |
allele *4 | 32 (12.3%) | 26 (14.0%) | 39 (10.3%) |
allele *5 | 7 (2.7%) | 2 (1.1%) | 13 (3.4%) |
allele *6 | 10 (3.8%) | 8 (4.3%) | 12 (3.2%) |
allele *7 | 19 (7.3%) | 12 (6.5%) | 23 (6.1%) |
allele *8 | 10 (3.8%) | 12 (6.5%) | 16 (4.2%) |
allele *9 | 15 (5.8%) | 10 (5.4%) | 23 (6.1%) |
allele *10 | 11 (4.2%) | 10 (5.4%) | 15 (3.9%) |
allele *11 | 17 (6.5%) | 12 (6.5%) | 37 (9.7%) |
allele *12 | 14 (5.4%) | 12 (6.5%) | 18 (4.7%) |
allele *13 | 10 (3.8%) | 7 (3.8%) | 10 (2.6%) |
allele *14 | 5 (1.9%) | 2 (1.1%) | 2 (0.5%) |
allele *15 | 1 (0.4%) | 0 (0%) | 1 (0.3%) |
allele *16 | 0 (0%) | 0 (0%) | 1 (0.3%) |
allele *17 | 1 (0.4%) | 1 (0.5%) | 0 (0%) |